Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Congenital Anomalies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01190267
What this trial is testing

Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)

Who this might be right for
Schizophrenia, ParanoidSchizophrenia, DisorganizedSchizophrenia, Undifferentiated
Organon and Co 204
Testing effectiveness (Phase 2)Study completedNCT01406977
What this trial is testing

Dose Escalation Study to Evaluate the Safety and Tolerability of Multiple Infusions of BPS804 in Adults With Hypophosphatasia (HPP)

Who this might be right for
Hypophosphatasia
Ultragenyx Pharmaceutical Inc 8
Not applicableUnknownNCT05500157
What this trial is testing

Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepatic Cysts

Who this might be right for
Liver CystPolycystic Liver DiseaseAutosomal Dominant Polycystic Kidney+1 more
Radboud University Medical Center 70
Testing effectiveness (Phase 2)Study completedNCT01828957
What this trial is testing

Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of BPD in Premature Infants

Who this might be right for
Bronchopulmonary Dysplasia
Medipost Co Ltd. 69
Not applicableUnknownNCT02887729
What this trial is testing

Analysis of Clinical and Molecular Genetic Data Influencing the Evolution and Response to Therapy of ADPKD Patients (Autosomal Dominant Polycystic Kidney Disease)

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
University Hospital, Brest 4,000
Testing effectiveness (Phase 2)Study completedNCT02000219
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis

Who this might be right for
Primary Hyperoxaluria
OxThera 12
Large-scale testing (Phase 3)Not Yet RecruitingNCT07218575
What this trial is testing

Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations

Who this might be right for
Cowden's DiseaseCowden's SyndromeLhermitte-Duclos Disease+6 more
Boston Children's Hospital 60
Early research (Phase 1)UnknownNCT05843305
What this trial is testing

BPI-452080 in Subjects With Solid Tumors

Who this might be right for
Solid TumorRenal Cell CarcinomaVon Hippel-Lindau Disease
Betta Pharmaceuticals Co., Ltd. 87
Not applicableLooking for participantsNCT07425769
What this trial is testing

Adapting RDAD for DS

Who this might be right for
Down Syndrome (DS)Alzheimer's Disease (AD)
University of Kansas Medical Center 40
Not applicableStudy completedNCT01122524
What this trial is testing

MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy

Who this might be right for
Pregnant WomenPrenatal Care
Verinata Health, Inc. 10,000
Not applicableStudy completedNCT01471639
What this trial is testing

An Efficacy and Safety Trial of Intranasal Ketorolac in Emergency Department Patients for the Treatment of Acute Pain

Who this might be right for
Other Acute Pain
The Cleveland Clinic 37
Testing effectiveness (Phase 2)Study completedNCT03340675
What this trial is testing

Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy CardiomyopathyCardiomyopathy, Dilated
Cumberland Pharmaceuticals 46
Large-scale testing (Phase 3)Looking for participantsNCT07605429
What this trial is testing

BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.

Who this might be right for
Angelman Syndrome
OHB Pediatrics Ltd. 165
Testing effectiveness (Phase 2)Study completedNCT04246372
What this trial is testing

Tofacitinib for Immune Skin Conditions in Down Syndrome

Who this might be right for
Down SyndromeAlopecia AreataAtopic Dermatitis / Eczema+3 more
University of Colorado, Denver 47
Not applicableLooking for participantsNCT05702645
What this trial is testing

Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia Associated With Down SyndromeDown SyndromeMyeloid Leukemia Associated With Down Syndrome
Children's Oncology Group 330
Not applicableStudy completedNCT04767412
What this trial is testing

Inspiratory Muscle Training and Physical Fitness in Children With Down Syndrome Randomized Control Trial

Who this might be right for
Down Syndrome
Cairo University 40
Not applicableLooking for participantsNCT05767203
What this trial is testing

Genetic Markers and Biomarkers in Patients With Intellectual Disabilities of Genetic Origin

Who this might be right for
Down SyndromeIntellectual Disability
Institut Jerome Lejeune 2,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05933603
What this trial is testing

Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome

Who this might be right for
Obstructive Sleep ApneaDown Syndrome
University of Arizona 36
Testing effectiveness (Phase 2)Looking for participantsNCT07429240
What this trial is testing

PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)

Who this might be right for
Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD
Precision BioSciences, Inc. 18
Not applicableEnded earlyNCT02654340
What this trial is testing

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Who this might be right for
Hypomelanotic MaculesFacial AngiofibromaShagreen Patches+6 more
CENTOGENE GmbH Rostock 20
Next Page